News SurgiMab Honored with the “Tech for Future 2025” Award in Healthcare by La Tribune, France – April 2, 20252 April 2025Françoise Cailler, CEO of surgiMab, will attend the WMIC2024 Congress in Montreal3 July 2024SurgiMab will sponsor the next edition of the International Symposium on Fluorescence Guided Surgery, 2-3 Nov 2023 in Amsterdam28 September 2023SurgiMab will participate to the conference “Optics in the Life Sciences” during the Optica Biophotonics Congress in Vancouver April 23 – 27, 202319 April 2023SurgiMab co-sponsors the Molecular-Guided Surgery meeting that will take place during the SPIE Photonics West conference in San Francisco on Jan 22-23, 2022.12 January 2022SurgiMab sponsors the conference “Molecular-Guided Surgery” of the SPIE Photonics West meeting – San Francisco, 1st and 2nd feb. 2020.29 January 2020SurgiMab announces recruitment of first US patient in pivotal Phase 3 clinical trial evaluating SGM-101 in colorectal cancer patients17 October 2019SurgiMab advances SGM-101 into pivotal Phase 3 clinical trial to improve surgical outcomes in colorectal cancer patients16 July 2019SGM-101 Clinical Results in Colorectal Cancer published in the Lancet Gastroenterology & Hepatology31 January 2018SurgiMab sponsors the “Molecular Guided Surgery” conference of the SPIE Photonics West meeting in San Francisco 27-28 January 201811 January 2018 Load more
SurgiMab Honored with the “Tech for Future 2025” Award in Healthcare by La Tribune, France – April 2, 20252 April 2025
SurgiMab will sponsor the next edition of the International Symposium on Fluorescence Guided Surgery, 2-3 Nov 2023 in Amsterdam28 September 2023
SurgiMab will participate to the conference “Optics in the Life Sciences” during the Optica Biophotonics Congress in Vancouver April 23 – 27, 202319 April 2023
SurgiMab co-sponsors the Molecular-Guided Surgery meeting that will take place during the SPIE Photonics West conference in San Francisco on Jan 22-23, 2022.12 January 2022
SurgiMab sponsors the conference “Molecular-Guided Surgery” of the SPIE Photonics West meeting – San Francisco, 1st and 2nd feb. 2020.29 January 2020
SurgiMab announces recruitment of first US patient in pivotal Phase 3 clinical trial evaluating SGM-101 in colorectal cancer patients17 October 2019
SurgiMab advances SGM-101 into pivotal Phase 3 clinical trial to improve surgical outcomes in colorectal cancer patients16 July 2019
SGM-101 Clinical Results in Colorectal Cancer published in the Lancet Gastroenterology & Hepatology31 January 2018
SurgiMab sponsors the “Molecular Guided Surgery” conference of the SPIE Photonics West meeting in San Francisco 27-28 January 201811 January 2018
